Nuvation Bio NUVB Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $125.39M-23.6% | $164.09M+65.9% | $98.9M-60.1% | $247.97M+417% | $47.98M+34.3% | ||
| $408.34M+11.8% | $365.13M-18.9% | $450.15M+25.1% | $359.75M-13.0% | $413.7M-11.4% | ||
| $49.82M+81.1% | $27.5M+13.9% | $24.15M+51.5% | $15.94M+19.3% | $13.36M+3.2% | ||
| $15.84M+38.8% | $11.41M+99.8% | $5.71M— | —— | —— | ||
| $591.53M+3.5% | $571.52M-1.0% | $577.53M-7.3% | $623.21M+31.0% | $475.57M-9.6% | ||
| $535K-5.1% | $564K+0.7% | $560K-8.9% | $615K+9.4% | $562K-4.1% | ||
| $10.76M-4.1% | $11.21M-4.0% | $11.68M-3.8% | $12.15M+175% | $4.41M— | ||
| $610.24M+2.6% | $594.82M-1.1% | $601.56M-7.1% | $647.23M+31.4% | $492.49M-8.9% | ||
| $69.69M+20.6% | $57.8M+5.7% | $54.66M+5.8% | $51.68M+49.9% | $34.48M+30.7% | ||
| $8.65M+15.1% | $7.52M+11.8% | $6.72M-30.9% | $9.73M-9.7% | $10.77M— | ||
| $5.79M+1.2% | $5.72M+1.9% | $5.62M+0.6% | $5.58M-1.8% | $5.69M— | ||
| $5.79M+1.2% | $5.72M+1.9% | $5.62M+0.6% | $5.58M-1.8% | $5.69M— | ||
| $79.52M-3.3% | $82.23M+20.7% | $68.13M+2.7% | $66.36M+25.7% | $52.77M-9.4% | ||
| $47.33M— | —— | —— | —— | —— | ||
| $290.68M+0.5% | $289.11M+4.9% | $275.68M+0.5% | $274.32M+276% | $73.03M-5.0% | ||
| $1.43B+0.7% | $1.42B+1.2% | $1.4B+0.6% | $1.4B+1.0% | $1.38B+299% | ||
| -$1.11B+0.5% | -$1.12B-3.4% | -$1.08B-5.5% | -$1.02B-6.1% | -$963.98M-5.8% | ||
| $319.56M+4.5% | $305.72M-6.2% | $325.88M-12.6% | $372.91M-11.1% | $419.46M-9.6% | ||
| $610.24M+2.6% | $594.82M-1.1% | $601.56M-7.1% | $647.23M+31.4% | $492.49M-8.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Nuvation Bio cover its short-term obligations?
- Its current ratio is 7.44 — current assets exceed current liabilities.
- Where does Nuvation Bio's balance sheet data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.